Cargando…
Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
Approximately two-thirds of children with acute myeloid leukemia (AML) are cured with intensive multi-agent chemotherapy. However, refractory and relapsed AML remains a significant source of childhood cancer mortality, highlighting the need for new therapies. Further therapy intensification with tra...
Autores principales: | Tasian, Sarah K., Pollard, Jessica A., Aplenc, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957536/ https://www.ncbi.nlm.nih.gov/pubmed/24672775 http://dx.doi.org/10.3389/fonc.2014.00055 |
Ejemplares similares
-
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023) -
Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
por: Izzo, Barbara, et al.
Publicado: (2019) -
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019) -
Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia
por: Sexauer, Amy N., et al.
Publicado: (2017) -
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023
por: Egan, Grace, et al.
Publicado: (2023)